Brink Therapeutics

Developer of cell and gene therapies to treat various diseases

placeParis, Ile De France, France calendar_todayFounded 2024 language brinktx.com

Social engagement

Social engagement: 2.1K social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Kurma Partners, Breega.

Investor typeCountShare
Venture capital440%
Other / undisclosed660%

Recent activity

16 Feb 2026
Recognition
Coming soon